glp-1/gip dual agonist weight loss Understand Tirzepatide and Its Effect on Current Therapy Upcoming wave of hormone-based therapies

FDA Food and Drug Administration

Moreover, for adults with type 2 diabetes or prediabetes and nonalcoholic fatty liver disease (NAFLD), the ADA suggests considering GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists as part of the treatment plan

Supports Healthy Metabolic Balance: Formulated with dihydroberberine, chromium, and green tea extract to help support the bodys natural metabolic processes and overall wellness.* Encourages Balanced Appetite Signals: Saffron extract and inositol help support a calm relationship with food and promote mindful eating habits.* Gentle Energy and Vitality Support: Green tea extract and Capsimax provide natural, mild thermogenic support to complement an active lifestyle.* Promotes Daily Wellness and Nutrient Processing: Designed to support the bodys natural ability to process nutrients efficiently as part of a balanced routine.* Premium, Clean, Science-Backed Formula: Vegan, non-GMO, and produced in a GMP-certified facility with no artificial fillers or unnecessary additives.*

2 Kidney Disease Risk Reduction In addition, the FDA has approved semaglutide (Ozempic) to slow the progression of kidney disease and reduce the risk of kidney failure, making it the most widely indicated GLP-1 drug

This created a massive market of affordable compounded tirzepatide at prices ranging from $200-500 per month